Bicocca Open Archive

Logo unimib boa
SALA, GESSICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.489
AS - Asia 6.018
EU - Europa 5.829
SA - Sud America 876
Continente sconosciuto - Info sul continente non disponibili 465
AF - Africa 151
OC - Oceania 10
Totale 24.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.920
SG - Singapore 1.984
IT - Italia 1.622
CN - Cina 1.382
VN - Vietnam 924
DE - Germania 820
RU - Federazione Russa 712
BR - Brasile 666
HK - Hong Kong 658
SE - Svezia 612
CA - Canada 458
IE - Irlanda 400
GB - Regno Unito 366
UA - Ucraina 317
IN - India 254
FR - Francia 216
FI - Finlandia 176
AT - Austria 148
BD - Bangladesh 112
KR - Corea 110
PL - Polonia 89
TR - Turchia 83
NL - Olanda 79
AR - Argentina 75
ES - Italia 72
IQ - Iraq 71
ID - Indonesia 68
JP - Giappone 63
MX - Messico 63
PK - Pakistan 57
DK - Danimarca 49
PH - Filippine 46
BE - Belgio 43
ZA - Sudafrica 40
IR - Iran 39
CO - Colombia 29
EC - Ecuador 29
EG - Egitto 25
SA - Arabia Saudita 25
VE - Venezuela 24
CH - Svizzera 22
UZ - Uzbekistan 21
KE - Kenya 19
ET - Etiopia 16
PY - Paraguay 16
MA - Marocco 15
MY - Malesia 15
JM - Giamaica 14
LT - Lituania 14
CL - Cile 13
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
JO - Giordania 11
EU - Europa 9
PE - Perù 9
PT - Portogallo 9
TW - Taiwan 9
DZ - Algeria 8
IL - Israele 8
NP - Nepal 8
AU - Australia 7
GR - Grecia 7
OM - Oman 7
SY - Repubblica araba siriana 7
TN - Tunisia 7
UY - Uruguay 7
KZ - Kazakistan 6
RO - Romania 6
BO - Bolivia 5
CR - Costa Rica 5
HN - Honduras 5
HU - Ungheria 5
LB - Libano 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LY - Libia 4
PS - Palestinian Territory 4
AL - Albania 3
BZ - Belize 3
CY - Cipro 3
GT - Guatemala 3
MU - Mauritius 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 24.351
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.609
Singapore 1.177
Ashburn 1.089
San Jose 680
Woodbridge 679
Hong Kong 628
Chandler 545
Milan 533
Frankfurt am Main 520
Houston 509
Fairfield 392
Dublin 383
Jacksonville 349
Wilmington 323
New York 311
Toronto 306
Ho Chi Minh City 278
Santa Clara 274
Dearborn 264
Dallas 261
Los Angeles 214
Hanoi 210
Beijing 190
Seattle 174
Princeton 152
Chicago 141
Cambridge 139
Vienna 129
The Dalles 117
Shanghai 112
Hefei 107
Rome 100
Nanjing 96
Boardman 93
Seoul 87
Lauterbourg 78
Buffalo 75
Council Bluffs 73
São Paulo 70
Helsinki 69
Lachine 61
Moscow 57
Altamura 54
Munich 54
Guangzhou 52
Da Nang 50
Jakarta 47
Lawrence 47
Orem 46
London 45
Kraków 44
Brussels 41
Chennai 38
Columbus 37
Tokyo 37
Fremont 36
Haiphong 35
Turin 35
Changsha 33
Shenyang 33
Pisa 32
Montreal 31
North Bergen 30
Atlanta 29
Secaucus 29
Warsaw 29
Nanchang 28
San Diego 28
Turku 28
Jinan 27
Tianjin 27
Brooklyn 26
Dong Ket 26
Phoenix 26
San Francisco 26
Denver 25
Andover 24
Baghdad 24
Pune 24
Rio de Janeiro 24
Zhengzhou 23
Amsterdam 22
Biên Hòa 22
Falls Church 22
Hebei 22
Newark 22
Piscataway 22
Grafing 21
Lahore 21
Monza 21
Ottawa 21
Zurich 21
New Delhi 20
Poplar 20
Belo Horizonte 19
Jiaxing 19
Johannesburg 19
Lecco 19
Manchester 19
Stockholm 18
Totale 15.374
Salva come PNG Salva come JPEG
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 659
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 539
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 497
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 459
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 434
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 433
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 415
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 393
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 378
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 374
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 368
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 366
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 362
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 356
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 356
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 349
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 349
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 337
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 335
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 331
Reduced platelet glutamate uptake in Parkinson's disease 329
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 326
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 326
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 319
New insights into the genetic etiology of Alzheimer's disease and related dementias 316
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 315
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 315
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 314
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 311
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 309
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 308
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 302
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 301
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 297
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 296
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 295
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 292
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 286
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 286
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 285
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 285
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 285
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 283
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 282
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 281
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 277
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 274
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 272
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 272
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 269
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 268
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 259
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 258
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 257
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 257
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 255
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 253
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 251
the MonzALS collaborative network 250
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 248
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 247
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 241
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 237
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 237
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 237
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 223
Macroautophagy is not altered in ALS lymphomonocytes 220
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 218
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 218
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 218
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 208
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 201
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 193
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 190
Assessing glutamatergic function and dysfunction in peripheral tissues 189
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 183
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 179
Whole-blood global DNA methylation and phenotypic variability in ALS 179
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 177
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 174
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 173
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 166
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 166
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 161
Platelets 138
Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC) 112
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 105
Effects of multidomain interventions on health outcomes in older adults: A systematic review and meta-analysis 38
NMR-based metabolic profiling of human plasma for the identification of biomarkers associated with ageing 34
Cholesterol in amyotrophic lateral sclerosis: a bystander, a biomarker, or a target? 22
Totale 24.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.120 97 126 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20253.377 170 407 276 135 253 185 161 139 318 549 278 506
2025/20269.574 1.107 571 689 934 1.000 463 1.474 403 908 893 566 566
2026/2027274 274 0 0 0 0 0 0 0 0 0 0 0
Totale 24.838